PerkinElmer
check quantity

IVISense Featured Probes Pack Fluorescent Imaging Panel

Get the flexibility you need with our IVISense Featured Probes Pack Fluorescent Imaigng Panel. This panel features a wide range of fluorescent probes specific to various disease areas as well as a fluorescent labeling kit to tag your own proteins, peptides or antibodies.

For research use only. Not for use in diagnostic procedures.

Part Number
List Price
Your Price
Quantity
NEV20011
2174.00 USD
 
more
Buy Now

Please enter valid quantity

Please log in to add favorites.

NULL OR EMPTY CART

Overview

PerkinElmer has developed a number of important fluorescence probes that allow imaging of a variety of disease or biological models. Our most popular probes have been selected based on the important biomarkers they target. These probes show broad utility in a number of applications, including cancer, angiogenesis, arthritis, cardiovascular disease, and acute inflammation. In addition, this panel includes IVISense™ 680 NHS Fluorescent Labeling Kit (VivoTag®), optimized for in vivo imaging, enabling researchers to tag their own proteins, peptides, or antibodies as either imaging tools or for assessing protein/antibody biodistribution.

The availability of probes at 680 nm and 750 nm wavelengths further offers the opportunity for multiplex imaging of appropriate probe combinations to maximize information gained from research animals.

 

The IVISense Featured Probes Pack Fluorescent Imaging Panel includes the following six probes:

Part Number Fluorescent Probe Biological Target
NEV10003 IVISense Pan Cathepsin 680 (ProSense 680) Pan-cathepsin activatable probe:
Lysosomal marker of inflammatory cells and tumor cells
NEV10054EX IVISense Vascular 680 (AngioSense 680EX) Vascular probe:
Leaks into sites of edema/cancer
NEV10040 IVISense Folate Receptor 680 (FolateRSense 680) Folate receptor targeted probe:
Marker on inflammatory cells; metabolic marker on tumor cells
NEV10168 IVISense MMP 750 FAST (MMPSense 750 FAST) Pan-MMP activatable probe:
Secreted marker of inflammatory cells, fibrosis, and tumor margins
NEV10873 IVISense Integrin Receptor 750 (IntegriSense 750) αVβ3 integrin targeted probe:
Marker on tumors, neovasculature, and osteoclasts
NEV11118 IVISense 680 NHS fluorescent dye (VivoTag 680XL Protein Labeling Kit) NIR fluorescence labeling kit:
Labeling antibodies, proteins, and peptides for in vivo imaging

Specifications

Optical Imaging Classification Fluorescence Imaging
Product Brand Name IVISense
Quantity in a Package Amount 6.0 Units
Shipping Condition Blue Ice
Unit Size 1 vial
Resources, Events & More
  • All

Ebook

In Vivo Imaging Solutions eBook

Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and therapeutic efficacies for a broad range of indications. Our reagents, instruments, and applications support have helped hundreds of research projects over the years. And our hard-earned expertise makes us a trusted provider of pre-clinical imaging solutions— with more than 9,000 peer reviewed articles as proof.

PDF 4 MB

Flyer

Best Practices for Designing An Effective In Vivo Fluorescence Imaging Study

Fluorescence molecular imaging is the visualization of cellular and biological function in vivo to gain deeper insights into disease processes and treatment effects. Designing an effective study from the beginning can help save time and resources.

Learn about several important best practices, from proper probe selection to study design to imaging technique tips and tricks needed to generate meaningful biological information from your in vivo fluorescence imaging studies.

PDF 507 KB
Fluorescent Panels Targeted for Your Research

Data sheet on PerkinElmer's Fluorescent Panels for In Vivo imaging

PDF 706 KB

Guide

Fluorescent Imaging Panels (User Guide)

User guide for fluorescent imaging probes

PDF 800 KB

White Paper

The Role of In Vivo Imaging in Drug Discovery and Development

The primary goal of preclinical imaging is to improve the odds of clinical success and reduce drug discovery and development time and costs. Advances in non-invasive in vivo imaging techniques have raised the use of animal models in drug discovery and development to a new level by enabling quick and efficient drug screening and evaluation. Read this White Paper to learn how preclinical in vivo imaging helps to ensure that smart choices are made by providing Go/No-Go decisions and de-risking drug candidates early on, significantly reducing time to the clinic and lowering costs all while maximizing biological understanding.

PDF 547 KB